Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Marijana Virijević"'
Autor:
Zorica Cvetković, Nikola Pantić, Mirjana Cvetković, Marijana Virijević, Nikica Sabljić, Gligorije Marinković, Vladimir Milosavljević, Zlatko Pravdić, Nada Suvajdžić-Vuković, Mirjana Mitrović
Publikováno v:
Diagnostics, Vol 13, Iss 18, p 2891 (2023)
Autoimmune hemolytic anemia (AIHA) is a rare, very heterogeneous, and sometimes life-threatening acquired hematologic disease characterized by increased red blood cell (RBC) destruction by autoantibodies (autoAbs), either with or without complement i
Externí odkaz:
https://doaj.org/article/5c301f79500c4e38b9396722f5bb6760
Autor:
Marijana Juga, Marijana Virijević
Publikováno v:
Srpski medicinski casopis Lekarske komore. 3:16-25
Introduction: Early death is a known complication in the treatment of patients suffering from acute myeloid leukemia (AML). It has been defined as death occurring within 28 days of the initiation of induction chemotherapy. Aim: Determining the clinic
Publikováno v:
Srpski medicinski casopis Lekarske komore. 2:342-351
Introduction: Acute lymphoblastic leukemia (ALL) is the malignant transformation and proliferation of lymphoid progenitor cells. The disease outcome is significantly influenced by cytogenetic and molecular characteristics, leukocyte levels, the perce
Autor:
Anka Poštić, Marijana Virijević
Publikováno v:
Srpski medicinski casopis Lekarske komore. 2:66-74
Introduction: Acute myeloid leukemia (AML) is characterized by pathological proliferation of myeloid lineages. It predominantly occurs in patients over 60 years of age, whose outcome is considerably worse, as compared to younger patients. Aim: The ai
Autor:
Dejan Dudok, Marijana Virijević
Publikováno v:
Srpski medicinski casopis Lekarske komore. 2:362-370
Introduction/Aim: Acute myeloid leukemia (AML) is a heterogenous malignant disease whose course and outcome are influenced by a number of prognostic factors. Serum ferritin (SF) is often elevated in oncology patients, and it has been shown that it st
Autor:
Mirjana Mitrović, Marijana Virijević, Zlatko Pravdić, Nikola Pantić, Nikica Sabljić, Nada Suvajdžić-Vuković
Publikováno v:
Srpski medicinski casopis Lekarske komore. 1:57-65
Autor:
Mirjana Mitrovic, Nikola Pantic, Zoran Bukumiric, Nikica Sabljic, Marijana Virijevic, Zlatko Pravdic, Mirjana Cvetkovic, Nikola Ilic, Jovan Rajic, Milena Todorovic-Balint, Ana Vidovic, Nada Suvajdzic-Vukovic, Jecko Thachil, Darko Antic
Publikováno v:
Thrombosis Journal, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Background Patients with acute myeloid leukemia (AML) are at increased risk of venous thromboembolic events (VTE). However, thromboprophylaxis is largely underused. Objectives This study aimed to determine possible VTE development risk facto
Externí odkaz:
https://doaj.org/article/5779e741e8a04875bbfd4e5dfe760715
Autor:
Ljubomir Jakovic, Vesna Djordjevic, Nada Kraguljac Kurtovic, Marijana Virijevic, Mirjana Mitrovic, Lazar Trajkovic, Ana Vidovic, Andrija Bogdanovic
Publikováno v:
Medicina, Vol 60, Iss 9, p 1443 (2024)
Background and Objectives: With the advent of novel therapies for nucleophosmin gene (NPM1)-mutated acute myeloid leukemia (AML), there is a growing need for the reliable prediction of NPM1 mutations. This study explored the role of cytomorphological
Externí odkaz:
https://doaj.org/article/2c777d71336f4e6cbe724bead21cb0ed
Autor:
Marijana, Virijević, Irena, Marjanovic, Marina, Andjelkovic, Teodora, Karan-Djurasevic, Branka, Zukic, Jovana, Komazec, Ivana, Grubisa, Biljana, Stankovic, Andrija, Bogdanović, Sonja, Pavlovic
Publikováno v:
Genetics & Applications; 2024 Special Issue, p42-42, 1p
Autor:
Sandra, Bižić Radulović, Vesna, Đorđević, Jelica, Jovanović, Vesna, Knežević, Nada, Kraguljac-Kurtović, Tijana, Dragović Ivančević, Ljubomir, Jaković, Mirjana, Mitrović, Marijana, Virijević, Ana, Vidović, Nada, Suvajdžić-Vuković, Andrija, Bogdanović
Publikováno v:
Genetics & Applications; 2024 Special Issue, p11-11, 1p